These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2358194)

  • 21. An evaluation of the TCu 380Ag and the Multiload Cu375.
    Cole LP; Potts DM; Aranda C; Behlilovic B; Etman ES; Moreno J; Randic L
    Fertil Steril; 1985 Feb; 43(2):214-7. PubMed ID: 3881295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
    Bilgehan F; Dilbaz B; Karadag B; Deveci CD
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuing IUD research.
    Netw Res Triangle Park N C; 1981 Jan; 2(2):4. PubMed ID: 12339100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical aspects of contraception by means of copper-7 and copper-T intrauterine devices].
    Peksa A; Sternadel Z
    Ginekol Pol; 1978 Sep; 49(9):781-5. PubMed ID: 730064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
    Makhlouf H; Abou-gabal A; El-hefnawi N; Khalifa A
    Popul Sci; 1988; (8):19-29. PubMed ID: 12343623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Four years of experience with the TCu 380A intrauterine contraceptive device.
    Sivin I; Tatum HJ
    Fertil Steril; 1981 Aug; 36(2):159-63. PubMed ID: 7262334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinically silent polymicrobial amnionitis and intrauterine fetal death associated with a Cu-7 intrauterine contraceptive device.
    Waites KB; Bobo RA; Davis RO; Brookings ES; Cassell GH
    Am J Obstet Gynecol; 1984 Dec; 150(8):998-9. PubMed ID: 6507538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrauterine rupture of the intrauterine device "ML Cu 250": an uncommon complication: presentation of a case.
    Custo G; Saitto C; Cerza S; Cosmi EV
    Fertil Steril; 1986 Jan; 45(1):130-1. PubMed ID: 3943643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Return of fertility after the removal of Nova T or copper T 200.
    Pyörälä T; Allonen H; Nygren KG; Nielsen NC; Luukkainen T
    Contraception; 1982 Aug; 26(2):113-20. PubMed ID: 7140291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of IUDs in developing countries: a comparative study.
    Farr G; Burdan A
    Netw Res Triangle Park N C; 1991 Sep; 12(2):6-8, 12. PubMed ID: 12284280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perinatal outcomes including long-term neuropsychiatric hospitalizations of offspring conceived during intrauterine contraceptive device use.
    Pariente G; Wainstock T; Sheiner E
    Contraception; 2019 Aug; 100(2):155-159. PubMed ID: 31004569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is diathermy safe in women with copper-bearing IUDs?
    Heick A; Espersen T; Pedersen HL; Raahauge J
    Acta Obstet Gynecol Scand; 1991; 70(2):153-5. PubMed ID: 1882662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degradation of the copper-releasing intrauterine contraceptive device and its significance.
    Chantler EN; Scott K; Filho CI; Elstein M; Faragher EB; Lorimer GW; Brough I
    Br J Obstet Gynaecol; 1984 Feb; 91(2):172-81. PubMed ID: 6696861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of intrauterine contraceptive devices in diabetics.
    Craig GM
    Br J Sex Med; 1982 Feb; 9():44-8. PubMed ID: 12279278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitrites and L-citrulline levels in copper intrauterine device users.
    Pradhan M; Gupta I; Ganguli NK
    Contraception; 1997 May; 55(5):315-8. PubMed ID: 9220230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrauterine contraceptive devices in diabetic women.
    Gosden C; Steel J; Ross A; Springbett A
    Lancet; 1982 Mar; 1(8271):530-5. PubMed ID: 6120391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copper release from copper intrauterine devices removed after up to 8 years of use.
    Kjaer A; Laursen K; Thormann L; Borggaard O; Lebech PE
    Contraception; 1993 Apr; 47(4):349-58. PubMed ID: 8508664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.